No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
317 |
4. Check minimum number of eventsNone |
317 |
5. Include endpointsNone |
317 |
6. Filter based on genotype QC (FinnGen only) |
317 |
Control definitions (FinnGen only)
- Control exclude
- MYELOPROF
Extra metadata
- First used in FinnGen datafreeze
- DF2, additional
Similar endpoints
↥List of similar endpoints to
Chronic myeloid leukaemia [CML], BCR/ABL-positive
based on the number of shared cases.
Similar with more cases:
- Myeloid leukaemia
- Myeloid leukaemia
- Myeloproliferative diseases
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2730 | 1222 | 1459 |
| Only index persons | 1748 | 801 | 947 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 61.57 | 61.90 | 61.03 |
| Only index persons | 59.17 | 59.30 | 59.06 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 317 | 144 | 173 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.08 |
| Median age at first event (years) | 58.29 | 57.54 | 58.92 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 306
- Matched controls
- 3062
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
323.0
304
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
536.0
308.5
271
43
189
Kela drug reimbursment
Imatinib
+∞
214.7
180
*
L01XE01
ATC
[U] imatinib; oral
+∞
182.0
156
*
XW000
NOMESCO Finland
Bone marrow biopsy
85.4
155.7
170
44
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
142.0
125
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
100.7
91
*
L01XX05
ATC
hydroxycarbamide; oral
1166.9
91.7
85
*
316
Kela drug reimbursment
Imatinib
+∞
89.0
81
*
M04AA01
ATC
allopurinol; systemic
12.2
76.6
167
274
152
Kela drug reimbursment
Nilotinib
+∞
66.1
61
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
170.7
65.9
67
5
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
112.9
59.5
63
7
150
Kela drug reimbursment
Dasatinib
+∞
51.5
48
*
L01XX28
ATC
[D] imatinib; oral
+∞
48.2
45
*
L01XE06
ATC
[U] dasatinib; systemic
+∞
46.0
43
*
L01XE08
ATC
[U] nilotinib; oral
+∞
43.8
41
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
39.2
35.2
44
13
328
Kela drug reimbursment
Nilotinib
+∞
34.0
32
*
L01EA03
ATC
nilotinib; oral
+∞
32.9
31
*
127
Kela drug reimbursment
Transplant complication
24.2
31.1
44
21
324
Kela drug reimbursment
Dasatinib
+∞
27.5
26
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
25.6
92
238
L03AA02
ATC
filgrastim; parenteral
11.8
24.6
46
45
212
Kela drug reimbursment
Gout
14.1
24.4
42
34
L01EA02
ATC
dasatinib; oral
+∞
22.1
21
*
R50.9
ICD-10 Finland
Fever, unspecified
4.4
20.8
86
251
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
20.0
19
*
WW500
NOMESCO Finland
Blood transfusion
9.8
19.1
39
45
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
18.9
18
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
18.9
18
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
201.8
18.7
19
*
A05AA02
ATC
ursodeoxycholic acid; oral
13.7
18.1
31
25
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.4
17.9
49
89
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
17.9
17
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
190.5
17.7
18
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
25.9
17.6
24
10
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
95.3
16.7
18
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
179.3
16.7
17
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
11.4
16.6
31
30
121
Kela drug reimbursment
Severe hypofunction of sexual glands
15.7
16.2
26
18
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
15.8
15
*
170
Kela drug reimbursment
Bosutinib
+∞
15.8
15
*
L04AA01
ATC
[U] ciclosporin; systemic
17.2
15.5
24
15
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
14.9
175
1026
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
35.8
13.6
17
5
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
13.6
13
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
13.6
62
192
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
42.1
13.3
16
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.0
13.0
32
50
C03CA01
ATC
furosemide; systemic
2.6
12.7
120
607
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
135.3
12.5
13
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
135.3
12.5
13
*
L01XE14
ATC
[U] bosutinib; oral
+∞
11.5
11
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
11.5
11
*
WW200
NOMESCO Finland
Immunization
6.7
11.2
28
45
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
45.0
11.0
13
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
62.2
10.7
12
*
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
113.7
10.5
11
*
L03AA04
ATC
NA
+∞
10.5
10
*
360
Kela drug reimbursment
Bosutinib
+∞
10.5
10
*
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
16.8
10.5
16
10
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.1
10.3
32
68
L04AD01
ATC
ciclosporin; systemic
9.6
10.2
20
22
B73
ICPC
Leukaemia
56.8
9.7
11
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
103.1
9.5
10
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
9.4
9
*
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
+∞
9.4
9
*
J05AB11
ATC
valaciclovir; oral
2.9
9.4
60
235
B03XA01
ATC
erythropoietin; parenteral
16.2
9.1
14
9
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
8.7
34
92
J02AC03
ATC
voriconazole; systemic
92.5
8.5
9
*
B03XA02
ATC
darbepoetin alfa; parenteral
7.4
8.4
19
27
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
8.4
8
*
WW409
NOMESCO Finland
Other aferesis
+∞
8.4
8
*
L01EA04
ATC
bosutinib; oral
+∞
8.4
8
*
A01AB04
ATC
amphotericin B; local oral
4.3
8.1
29
72
C82.1
ICD-10 Finland
Follicular lymphoma grade II
22.7
8.1
11
5
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
22.7
8.1
11
5
J05AB01
ATC
aciclovir; systemic
2.3
7.8
79
399
L01BB02
ATC
mercaptopurine; oral
15.5
7.8
12
8
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.0
7.8
45
166
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
46.2
7.8
9
*
J01MA14
ATC
moxifloxacin; systemic
3.1
7.6
42
147
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
7.5
86
457
A04AA01
ATC
ondansetron; systemic, rectal
3.6
7.4
32
95
373
Kela drug reimbursment
Ponatinib
+∞
7.3
7
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
7.3
7
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
7.3
65
307
A41.9
ICD-10 Finland
Sepsis, unspecified
5.2
7.1
21
43
H02AB09
ATC
hydrocortisone; systemic
7.4
6.8
15
21
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
41.0
6.8
8
*
H02AB06
ATC
prednisolone; systemic
1.9
6.8
146
991
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.3
6.8
24
60
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
6.6
67
336
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
6.5
42
166
D75.2
ICD-10 Finland
Essential thrombocytosis
71.3
6.4
7
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
6.4
44
180
C91.2
ICD-10 Finland
Subacute lymphocytic leukemia
+∞
6.3
6
*
L01XE24
ATC
[U] ponatinib; oral
+∞
6.3
6
*
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
6.1
58
284
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
91
19
66.78
161.36
1.5
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
96
45
30.17
134.25
2.4
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
145
213
11.70
103.95
4.5
2.8
e9/l
68.4
68.3
0.01
110
165
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
89
0
+∞
98.14
15.7
0.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
87
0
+∞
95.80
11.7
0.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
161
304
9.73
92.54
5.4
2.6
%
1.8
1.8
0.18
155
278
(3017181) Myelocytes/100 leukocytes in Blood
116
227
7.48
61.72
9.0
4.6
%
2.7
0.8
4.20
61
76
(3002179) Metamyelocytes/100 leukocytes in Blood
101
204
6.80
51.28
8.7
4.7
%
1.6
0.3
3.80
39
54
(42870588) Differential panel, method unspecified - Blood
215
844
5.81
51.09
20.5
5.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
41
30
15.55
45.04
1.3
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
259
1288
6.52
43.65
20.4
5.6
e9/l
0.6
0.6
0.58
250
1119
(3006315) Basophils [#/volume] in Blood
259
1294
6.47
43.23
20.5
5.6
e9/l
0.0
0.0
0.29
249
1127
(3026493) Urate [Moles/volume] in Serum or Plasma
183
697
4.85
43.20
6.6
2.7
umol/l
339.5
8174.3
3.52
175
596
(3013115) Eosinophils [#/volume] in Blood
261
1328
6.46
42.15
22.3
5.8
e9/l
0.2
0.2
1.84
253
1177
(3019198) Lymphocytes [#/volume] in Blood
260
1322
6.38
41.92
20.6
5.6
e9/l
2.0
1.9
0.13
251
1174
(3021440) Promyelocytes/100 leukocytes in Blood
93
214
5.73
40.38
10.4
4.8
%
0.4
0.2
1.23
58
69
(3005719) IgG [Mass/volume] in Serum or Plasma
91
206
5.79
40.22
2.3
2.7
g/l
8.8
10.5
3.82
85
183
(3025159) Blasts/100 leukocytes in Blood
88
203
5.62
37.93
9.8
4.8
%
1.3
0.2
0.59
44
60
(3013650) Neutrophils [#/volume] in Blood by Automated count
265
1492
5.73
34.28
29.2
9.2
e9/l
3.6
4.1
2.81
255
1310
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
42
50
9.53
33.40
10.0
6.6
iu/ml
181.1
117.3
—
10
7
(40760892) CBC W Ordered Manual Differential panel - Blood
143
560
3.83
30.08
14.9
5.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
70
161
5.30
29.82
1.3
1.9
g/l
1.1
1.4
0.43
65
146
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
59
117
5.97
29.56
1.8
1.8
g/l
1.3
1.5
1.02
52
101
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
38
50
8.50
27.80
1.2
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
44
8.82
26.53
1.1
1.3
u/ml
138.3
89.3
—
9
8
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
230
1297
3.82
26.31
15.0
6.8
mmol/l
1.2
1.2
0.33
203
1098
(3021879) Hepatitis B virus core Ab [Presence] in Serum
66
170
4.64
24.28
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
41
71
6.48
23.39
1.7
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
19
11
18.31
23.08
1.8
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
162
785
3.18
22.76
11.3
4.0
ph
7.4
7.4
0.76
31
147
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
41
8.27
22.48
6.6
3.9
%
53.2
57.4
0.75
31
41
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
209
1185
3.24
22.09
13.5
5.8
mmol/l
1.2
1.2
0.28
201
1068
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
28
34
8.94
21.72
2.2
2.0
pg
33.6
33.1
0.26
28
34
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
39
7.78
19.39
6.5
3.7
e9/l
3.0
4.6
2.33
28
39
(44790048)
24
28
9.19
19.14
1.6
1.6
—
—
—
0
0
(44790049)
24
28
9.19
19.14
1.6
1.6
—
—
—
0
0
(44806118)
24
28
9.19
19.14
1.6
1.6
—
—
—
0
0
(44790047)
24
28
9.19
19.14
1.6
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
20
18
11.79
19.06
4.1
3.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
95
374
3.20
18.47
3.2
2.3
%
22.8
22.4
0.09
83
321
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
66
5.84
18.23
2.5
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
35
66
5.84
18.23
2.3
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
21
10.10
17.17
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
33
7.79
16.76
10.9
3.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
22
9.64
16.60
2.2
2.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
25
8.47
15.05
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
21
28
7.96
15.01
8.3
2.8
%
46.8
59.5
1.05
13
19
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
26
8.14
14.58
4.1
2.0
e6/l
726.7
555.1
—
7
11
(3021589) Normoblasts [#/volume] in Blood
185
1132
2.52
14.45
27.0
9.8
e9/l
0.0
0.0
0.61
172
929
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
148
826
2.49
14.00
3.3
2.5
u/l
58.2
56.6
0.24
143
759
(40758558) Short blood count panel - Blood
123
640
2.51
13.43
21.7
6.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
53
5.48
13.41
1.1
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
135
737
2.45
13.24
7.0
4.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
224
1536
2.56
13.13
8.4
4.6
mmol/l
6.7
6.7
0.01
218
1442
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
122
638
2.48
13.12
2.8
2.0
mg/l
2.8
3.1
0.65
112
545
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
36
6.49
13.11
1.0
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
123
649
2.46
12.94
7.4
3.8
%
90.7
90.1
0.09
117
638
(3001122) Ferritin [Mass/volume] in Serum or Plasma
170
1039
2.37
12.79
4.3
2.6
ug/l
263.9
149.0
2.56
165
951
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
76
319
2.82
12.73
1.6
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
74
4.53
12.29
1.1
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
90
419
2.60
12.26
2.8
2.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
50
5.34
12.16
1.1
1.2
u/ml
352.1
261.7
0.52
19
30
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
51
5.24
11.89
2.5
1.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
41
5.69
11.52
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
66
279
2.72
10.78
1.6
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
49
4.98
10.41
1.8
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
16
25
6.69
9.90
4.4
2.0
e9/l
0.9
1.2
—
10
10
(3032080) INR in Blood by Coagulation assay
164
1061
2.13
9.90
7.0
9.2
inr
1.2
1.3
0.73
45
307
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
40
5.27
9.70
1.6
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
164
3.03
9.61
3.0
2.5
e9/l
7.4
3.8
0.64
38
127
(3044640) Blood type and Crossmatch panel - Blood
134
810
2.13
9.59
5.7
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
49
188
2.90
9.55
1.8
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
149
943
2.09
9.39
4.3
3.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
48
185
2.88
9.27
1.3
3.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
66
300
2.52
9.23
2.5
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
66
301
2.51
9.16
2.5
1.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
14
9
16.20
9.11
1.2
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
18
7.49
8.91
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
89
3.62
8.87
2.4
2.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
32
5.56
8.78
2.6
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
75
3.84
8.76
1.7
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
13
8.73
8.51
3.5
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
26
6.01
8.41
2.8
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
26
6.01
8.41
2.8
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
26
6.01
8.41
2.8
1.9
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
13
9
14.99
8.27
4.1
3.9
%
50.2
51.7
—
13
9
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
173
1193
1.99
8.26
8.2
4.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
23
6.32
8.25
1.1
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
42
4.75
8.23
2.0
1.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
35
5.08
7.98
2.6
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
134
858
1.97
7.81
6.6
3.3
u/l
39.9
33.8
0.42
128
819
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
72
3.68
7.71
1.4
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
32
109
3.15
7.64
2.6
1.9
ug/l
1.9
4.8
0.51
32
99
(3007164) IgA [Mass/volume] in Serum or Plasma
88
490
2.10
7.51
1.5
1.4
g/l
2.1
2.6
2.25
69
294
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
26
5.59
7.31
1.6
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
130
848
1.90
6.99
6.8
3.3
mmol/l
2.3
2.4
2.31
124
743
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
93
544
2.00
6.87
1.9
1.7
mg/l
1.6
1.3
0.44
76
412
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
36
4.63
6.78
1.9
2.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
14
7.34
6.73
1.8
2.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
21
5.90
6.63
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
25
5.38
6.54
3.2
2.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
18
6.29
6.47
1.6
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
18
6.29
6.47
1.6
1.7
—
—
—
0
0
(4212803)
6
0
+∞
6.27
1.0
0.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
70
389
2.03
5.88
1.7
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
32
4.53
5.82
1.9
1.8
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
24
5.16
5.79
1.8
1.3
e6/l
20620.5
44514.2
—
6
16
(3007853) Bacteria identified in Skin by Aerobe culture
58
303
2.12
5.74
2.1
1.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
57
297
2.12
5.68
9.5
7.2
kpa
12.2
12.0
0.12
52
286
(3000012) Reticulocyte production index
10
17
6.04
5.66
1.7
2.2
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
12
25
4.95
5.54
1.5
1.3
u/l
377.1
264.9
0.26
12
25
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
38
4.09
5.50
2.0
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
101
649
1.82
5.44
1.9
1.6
nmol/l
19.6
20.7
0.35
92
552
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
5
16.35
5.44
1.4
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
85
518
1.88
5.42
1.8
1.7
nmol/l
1246.0
1183.8
0.25
79
383
(3003396) Base excess in Arterial blood by calculation
56
300
2.05
5.17
9.6
7.2
mmol/l
1.1
1.1
0.01
39
246
(3042936) Bacteria identified in Isolate by Culture
68
392
1.94
5.11
2.0
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
51
3.47
4.96
2.2
3.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
172
2.30
4.85
3.7
2.9
mmol/l
0.3
1.5
0.87
25
125
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
146
1074
1.67
4.71
2.3
2.0
pmol/l
92.6
95.9
0.34
101
556
(3024471) HLA-A [Type]
7
5
14.27
4.59
1.0
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
93
614
1.73
4.45
6.0
2.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
34
160
2.26
4.34
1.9
1.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
6
11.89
4.29
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
27
4.18
4.19
1.5
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
17
58
3.04
4.07
1.0
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
64
2.92
4.03
1.9
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
9
14
6.58
4.01
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
19
71
2.78
3.90
1.4
4.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
15
6.14
3.84
3.6
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
15
6.14
3.84
3.6
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
15
6.14
3.84
3.6
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
15
6.14
3.84
3.6
1.9
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
5
12.19
3.77
1.5
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
103
2.44
3.77
1.4
2.9
g/l
8.4
10.3
1.82
16
93
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
12
6.81
3.69
3.7
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
12
6.81
3.69
3.7
2.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
56
2.96
3.68
1.8
2.4
g/l
129.4
129.6
—
10
40
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
105
2.39
3.62
1.5
2.8
g/l
3.3
3.2
0.19
15
86
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
136
1031
1.56
3.62
3.8
3.7
ng/l
24.6
41.0
1.89
111
740
(3002582) Erythrocytes [#/volume] in Urine
111
804
1.59
3.59
4.8
3.2
e6/l
28.8
147.6
0.83
96
617
(3013707) Erythrocyte sedimentation rate by Westergren method
227
1933
1.61
3.59
6.1
4.1
mm/h
14.0
12.2
1.07
220
1760
(3000850) Epithelial cells [#/volume] in Urine
81
544
1.66
3.56
3.3
2.6
e6/l
5.0
4.5
0.18
76
481
(3002032) Base excess in Venous blood by calculation
43
240
1.92
3.53
5.5
3.8
mmol/l
2.5
2.0
0.25
35
192
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
13
6.28
3.52
3.6
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
113
2.32
3.52
1.5
2.7
g/l
7.1
7.4
0.30
15
89
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
113
2.32
3.52
1.5
2.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
113
2.32
3.52
1.5
2.7
g/l
3.6
3.8
0.28
15
85
(3025941) Bacteria identified in Stool by Culture
30
147
2.15
3.49
1.6
1.2
—
—
—
0
0
(3012544) pH of Venous blood
44
251
1.87
3.38
5.5
3.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
14
5.83
3.36
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
14
5.83
3.36
1.3
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
165
2.04
3.28
1.7
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
39
216
1.92
3.28
2.8
3.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
7
8.71
3.27
1.7
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
21
91
2.40
3.25
1.4
4.3
—
2.8
—
0
9
(3019060) Gas panel - Arterial blood
34
180
2.00
3.25
4.0
4.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
54
333
1.75
3.23
1.3
1.4
titre
349.1
459.7
0.31
11
73
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
11
6.48
3.20
7.6
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
11
6.48
3.20
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
44
3.04
3.17
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
476
1.63
3.12
4.2
3.0
mmol/l
2.4
2.5
0.08
71
423
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
93
2.35
3.10
3.6
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
96
695
1.55
3.04
4.5
3.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
51
316
1.73
3.00
2.0
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
17
70
2.51
2.93
1.1
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
13
5.48
2.88
1.4
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
36
3.13
2.83
1.1
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
23
111
2.16
2.80
4.4
3.1
mmol/l
24.3
24.6
0.15
23
106
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
14
5.09
2.74
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
14
5.09
2.74
1.3
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
10
6.09
2.71
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
10
6.09
2.71
1.0
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
73
2.40
2.70
2.9
2.1
u/ml
0.3
0.4
0.08
12
35
(3014576) Chloride [Moles/volume] in Serum or Plasma
53
343
1.65
2.66
13.8
6.7
mmol/l
104.0
103.9
0.07
53
331
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
74
2.37
2.63
2.3
1.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
7
7.23
2.56
1.2
1.0
%
109.0
147.1
—
5
7
(4035726)
38
227
1.77
2.54
1.5
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
69
485
1.54
2.46
6.0
3.6
ng/l
133.1
165.7
0.13
59
383
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
90
2.18
2.44
2.3
1.8
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
12
5.07
2.41
1.8
1.4
%
1.0
1.5
—
6
7
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
71
2.32
2.38
1.6
1.4
ug/g
237.1
316.9
—
9
41
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
41
2.74
2.30
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
97
741
1.45
2.29
4.6
3.1
e6/l
0.6
0.5
0.09
85
548
(3044889) 12 lead EKG panel
208
1819
1.42
2.26
5.4
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
88
664
1.45
2.21
1.5
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
116
921
1.41
2.21
5.6
3.7
e6/l
87.8
89.6
0.01
102
661
(3022313) Gas panel - Capillary blood
25
137
1.90
2.21
4.5
2.7
—
—
—
0
0
(3019225) pH of Specimen
39
245
1.67
2.20
7.9
4.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
24
3.39
2.19
1.1
3.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
14
4.35
2.16
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
14
4.35
2.16
1.7
1.9
u/ml
991.7
996.3
—
6
14
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
49
2.51
2.13
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
49
2.51
2.13
1.3
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
19
96
2.04
2.10
1.4
1.8
—
144.0
—
0
5
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
212
1872
1.40
2.09
4.1
3.7
pmol/l
15.1
14.8
0.62
204
1673
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
10
5.06
2.08
17.4
3.8
u/l
189.6
201.1
—
5
10
(3045788) Cell count panel - Pleural fluid
7
20
3.55
2.06
1.9
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
83
2.11
2.05
4.7
3.3
—
—
—
0
0
(3017704) Immunofixation for Urine
6
15
4.06
2.05
1.5
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
32
2.86
2.01
1.3
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
11
46
2.44
1.87
1.4
2.1
u/l
59331.6
5247.2
—
5
18
(3037467) Urinalysis macro (dipstick) panel - Urine
199
1757
1.36
1.85
5.2
4.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
12
4.21
1.83
3.4
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
47
2.39
1.79
1.2
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
47
2.39
1.79
2.5
2.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
59
430
1.46
1.76
4.7
2.8
e6/l
2.3
1.8
0.20
39
234
(3000991) Gas panel - Venous blood
33
213
1.61
1.71
16.2
8.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
12
55
2.23
1.69
3.0
3.0
mmol/l
3.0
2.4
—
6
32
(3023410) Appearance of Cerebral spinal fluid
6
19
3.20
1.67
5.2
1.5
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
7
25
2.84
1.66
1.0
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
148
1266
1.32
1.64
3.7
3.8
estimate
0.0
0.0
0.00
25
231
(3003327) Ova and parasites identified in Stool by Light microscopy
15
77
2.00
1.62
1.3
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
137
1.73
1.60
2.5
2.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
26
2.73
1.59
1.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
20
3.04
1.59
2.0
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
201
1.60
1.58
4.2
2.9
ml/min/173m2
57.2
62.8
0.53
21
87
(21494755) Public health laboratory ask at order entry panel
12
230
0.50
1.56
1.3
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
21
2.89
1.51
6.8
3.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
58
2.11
1.51
2.3
2.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
132
1.72
1.50
19.6
8.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
145
1250
1.29
1.47
4.8
5.1
estimate
0.0
0.0
0.00
30
237
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
59
2.07
1.45
1.7
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
22
2.76
1.44
1.0
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
117
983
1.30
1.44
2.4
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
67
1.98
1.40
1.3
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
31
208
1.54
1.39
4.0
3.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
41
2.23
1.38
1.3
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
23
2.64
1.37
1.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
23
2.64
1.37
1.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
23
2.64
1.37
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
17
2.97
1.36
4.6
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
42
2.18
1.35
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
42
2.18
1.35
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
42
2.18
1.35
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
42
2.18
1.35
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
43
2.12
1.31
1.3
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
70
556
1.33
1.27
3.9
3.9
kg/l
1.0
1.0
2.18
13
78
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
272
2575
1.40
1.27
36.8
14.4
mg/l
19.8
24.3
1.51
249
2030
(3002385) Erythrocyte distribution width [Ratio]
229
2116
1.30
1.26
47.7
17.7
%
14.7
13.7
16.46
229
2076
(3007566) Smooth muscle Ab [Titer] in Serum
13
70
1.89
1.26
1.1
1.3
—
61.7
—
0
6
(3010421) pH of Blood
12
63
1.94
1.24
3.0
3.0
ph
7.4
7.4
0.11
12
54
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
169
1512
1.25
1.19
2.7
2.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
1.7
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
1.7
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
26
2.33
1.19
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
102
1.70
1.19
1.9
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
142
1247
1.25
1.17
3.7
3.7
estimate
0.0
0.0
0.00
28
241
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
20
2.52
1.15
2.2
1.7
nmol/l
0.3
0.2
—
5
14
(3012516) Albumin [Mass/volume] in Urine
92
769
1.28
1.15
3.6
3.2
mg/l
3232.2
144.2
1.56
67
497
(21494890) Protein electrophoresis panel - 24 hour Urine
7
30
2.36
1.13
1.0
2.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
41
306
1.39
1.11
2.1
2.3
ug/g
235.4
143.3
0.51
31
243
(3041354) Potassium [Moles/volume] in Venous blood
8
41
1.98
1.09
2.4
2.9
mmol/l
4.0
4.0
—
8
41
(3035285) Chloride [Moles/volume] in Venous blood
8
41
1.98
1.09
2.4
2.9
mmol/l
106.0
105.6
—
8
41
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
41
1.98
1.09
2.4
2.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
21
2.40
1.09
2.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
48
1.90
1.01
3.0
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
575
1.28
1.00
3.2
3.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
90
764
1.25
0.98
3.5
3.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
23
2.19
0.98
1.2
3.2
u/ml
19.6
64.3
—
5
23
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
126
1.54
0.93
1.2
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
110
1.58
0.92
1.3
1.3
—
—
—
0
0
(4062490)
6
28
2.16
0.92
1.3
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
63
1.77
0.91
2.8
1.7
pmol/l
174.9
248.9
1.69
11
57
(3014051) Protein [Presence] in Urine by Test strip
10
56
1.81
0.89
2.2
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
81
688
1.24
0.88
4.1
4.0
estimate
0.0
0.0
0.00
25
232
(3000330) Specific gravity of Urine by Test strip
20
137
1.49
0.86
2.6
4.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
258
1.36
0.86
4.1
3.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
21
146
1.47
0.85
1.4
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
32
1.89
0.82
6.8
3.0
—
—
—
0
0
(4268621)
6
32
1.89
0.82
2.0
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
39
306
1.31
0.80
1.3
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
(3013512) EKG study
91
793
1.21
0.77
3.8
3.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
83
1.59
0.76
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
75
1.62
0.76
2.2
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
24
2.10
0.75
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
38
1.86
0.74
1.7
1.7
%
90.6
90.2
—
7
38
(3043409) Potassium [Moles/volume] in Arterial blood
14
92
1.55
0.73
2.5
3.3
mmol/l
4.0
4.0
0.03
14
81
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
84
1.57
0.73
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
25
2.02
0.73
1.4
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
21
152
1.41
0.71
1.6
1.3
—
27.1
—
0
9
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
55
459
1.24
0.71
3.9
2.6
e6/l
1.5
1.0
0.63
37
260
(3029634) Reagin Ab [Titer] in Serum by VDRL
5
26
1.94
0.71
1.0
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
85
1.55
0.70
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
313
1.28
0.69
10.7
7.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
93
821
1.19
0.68
4.3
4.0
mg/mmol
19.7
9.7
0.70
61
524
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
49
586
0.81
0.68
2.5
3.1
ug/l
0.7
0.8
0.28
31
385
(3002256) Pathology report gross observation
38
305
1.28
0.67
1.3
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
240
2291
1.20
0.67
5.1
4.6
mu/l
1.9
1.9
0.26
231
2068
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
110
988
1.17
0.66
3.9
3.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
62
1.63
0.66
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
181
1.35
0.65
2.5
2.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
64
548
1.21
0.65
1.5
1.8
pmol/l
501.1
12780704.5
0.50
51
446
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
50
1.62
0.61
1.0
1.9
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
30
1.68
0.61
1.0
2.1
ug/l
15.2
17.0
—
5
30
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
30
1.68
0.61
1.0
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
41
339
1.24
0.58
22.8
23.0
inr
1.3
1.3
—
6
43
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
277
2840
0.80
0.58
55.1
21.1
e9/l
8.1
6.7
0.76
272
2754
(40761511) CBC panel - Blood by Automated count
260
2681
0.83
0.58
28.1
13.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
277
2839
0.81
0.57
54.9
21.0
e12/l
4.0
4.5
25.09
272
2754
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
55
1.47
0.56
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
125
0.63
0.55
1.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
253
2440
1.18
0.55
5.0
4.0
mmol/l
1.6
1.3
1.51
244
2228
(3009508) Creatinine [Moles/volume] in Urine
90
807
1.16
0.55
3.5
3.1
mmol/l
8.2
7.8
0.38
77
668
(3020891) Body temperature
14
101
1.40
0.50
4.5
4.1
—
—
—
0
0
(4094501)
11
78
1.43
0.43
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
418
1.17
0.43
1.2
1.3
u/ml
1.3
14.3
2.56
17
159
(4034850)
6
92
0.65
0.43
8.2
8.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
206
0.76
0.43
1.8
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
32
1.57
0.42
3.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
32
1.57
0.42
3.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
72
795
0.88
0.41
3.6
4.3
%
23.8
21.7
0.53
37
378
(1002224) Polysomnography panel
7
105
0.66
0.40
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
35
1.44
0.39
1.2
1.2
—
—
—
0
0
(4010399)
15
192
0.77
0.39
1.7
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
36
1.39
0.38
2.0
3.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
41
357
1.17
0.37
1.2
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
37
1.36
0.37
2.8
3.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
41
1.47
0.36
1.2
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
84
910
0.90
0.35
3.3
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
77
706
1.12
0.34
3.7
3.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
21
174
1.22
0.32
3.0
2.5
—
9.0
—
0
7
(3024928) Oxygen saturation in Venous blood
7
54
1.30
0.30
2.4
2.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
139
0.78
0.27
1.0
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
49
445
1.12
0.26
1.2
1.3
iu/ml
17.1
37.8
2.24
16
147
(3039443) Prostate specific Ag panel - Serum or Plasma
8
67
1.20
0.26
2.0
1.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
15
123
1.23
0.26
1.6
2.9
u/ml
29.3
70.9
0.67
15
118
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
680
1.10
0.25
1.7
1.6
mmol/l
2.1
1.4
1.09
65
570
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
179
1731
1.08
0.25
3.4
3.2
u/l
61.7
50.3
0.64
169
1614
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
81
0.74
0.24
1.3
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
38
1.32
0.23
1.4
1.2
—
1.1
—
0
9
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
93
0.75
0.22
2.3
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
40
1.25
0.22
1.0
2.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
9.1
—
0
13
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
2.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
247
2428
1.08
0.19
31.9
13.7
ml/min/173m2
74.2
79.8
3.20
228
2000
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
196
0.86
0.19
1.5
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
60
1.17
0.18
1.4
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
60
1.17
0.18
1.1
1.2
—
1.1
—
0
5
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
184
0.86
0.17
1.4
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
152
0.85
0.17
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
35
322
1.10
0.16
1.5
1.9
%
1.4
1.5
0.62
28
290
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
71
1.13
0.16
2.0
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
83
1.21
0.15
2.0
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
182
0.87
0.15
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
83
1.09
0.15
3.8
5.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
200
0.89
0.13
1.5
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
255
2526
1.05
0.09
5.4
4.5
mmol/l
4.3
4.6
4.84
250
2332
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
56
1.07
0.08
1.0
1.3
—
46.6
—
0
6
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
66
1.06
0.08
1.1
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
68
1.03
0.08
1.1
1.3
—
2.8
—
0
11
(3016879) Cocaine [Presence] in Urine
8
76
1.05
0.07
1.0
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
241
2393
1.03
0.05
6.3
6.0
mmol/mol
39.1
40.3
1.67
229
2220
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
253
2515
1.03
0.05
5.2
4.4
mmol/l
1.3
1.5
6.69
246
2313
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
257
2583
0.97
0.04
5.7
5.0
mmol/l
2.5
2.7
4.92
249
2372
(3009542) Hematocrit [Volume Fraction] of Blood
229
2304
0.98
0.04
38.5
15.3
%
37.0
40.1
4.84
152
1654
(3000492) Spirometry study
23
239
0.96
0.03
2.1
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
53
540
0.98
0.02
1.2
1.2
u/ml
1.0
1.4
—
9
147
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
41
401
1.03
0.02
1.7
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
99
999
0.99
0.01
4.2
4.9
ug/l
7.5
2.6
0.40
91
882
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
248
2487
0.99
0.01
5.4
4.7
mmol/l
6.1
6.0
0.95
234
2264
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
154
1.04
0.00
1.2
1.3
iu/ml
30.7
152.5
—
6
55
(3049717) Cytology report of Urine Cyto stain
11
112
0.98
0.00
3.6
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
302
0.99
0.00
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
257
1.01
0.00
1.7
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
56
0.89
0.00
1.2
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.6
—
5.8
—
0
9
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1350.8
—
0
6
(3000764) Benzodiazepines [Presence] in Urine
8
79
1.01
0.00
1.0
2.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
80
1.00
0.00
1.0
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
2.1
—
0
5
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
44.8
—
0
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
54
0.92
0.00
1.2
3.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
61
0.98
0.00
1.0
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
81
0.99
0.00
1.0
2.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
53
0.94
0.00
1.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
1.1
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
70
1.00
0.00
1.1
1.3
—
8.4
—
0
13
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
81
0.99
0.00
1.0
2.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CML and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CML | 4.426 [3.35, 5.85] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.636 |
During the follow-up period (1.1.1998 — 31.12.2019), 322 out of 808 females with CML died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CML | 3.628 [2.8, 4.71] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 423 out of 944 males with CML died.
Mortality risk
Mortality risk for people of age
years, who have CML.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.525% | 0.565% |
| 5 | 2.993% | 4.051% |
| 10 | 7.101% | 9.458% |
| 15 | 13.164% | 18.283% |
| 20 | 22.051% | 29.576% |
Relationships between endpoints
↥Index endpoint: CML – Chronic myeloid leukaemia [CML], BCR/ABL-positive
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data